IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-05086560.html
   My bibliography  Save this paper

Drug deprescribing policy and incentives in France

Author

Listed:
  • Francis Megerlin

    (CEIE - Centre d'études internationales et européennes - UNISTRA - Université de Strasbourg, Académie nationale de Pharmacie)

  • Gilles Bouvenot

    (INSERM - Institut National de la Santé et de la Recherche Médicale, Académie nationale de médecine)

  • Patrice Queneau

    (Service de Médecine interne [CHU Saint-Etienne] - CHU ST-E - Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] - UJM - Université Jean Monnet - Saint-Étienne, Académie nationale de médecine)

Abstract

Deprescribing inappropriate drug treatments is a public health issue particularly in countries with a high level of polymedication (polypharmacy). Despite the introduction of the term ‘deprescribing' in France in 2002 and the clinical practice guidelines, progress in the outpatient sector has been limited. Our article describes the financial incentives adopted by national agreements between the Assurance Maladie (France's compulsory health insurer scheme) and unions of independent practitioners: pharmacists are encouraged to draw up and share medication reviews (since 2018, target population extended in 2022). As the outcomes have been modest, doctors have then been since 2024 also incentivised to offer medical consultations explicitly dedicated to deprescribing, and to prescribe medication reviews to be drawn up by pharmacists. This article describes the new legal framework for outpatient and inpatient services. It calls for the results expected from 2025 onwards to be measured and studied in national health databases, thanks to the coding associated with these new services.

Suggested Citation

  • Francis Megerlin & Gilles Bouvenot & Patrice Queneau, 2025. "Drug deprescribing policy and incentives in France," Post-Print hal-05086560, HAL.
  • Handle: RePEc:hal:journl:hal-05086560
    DOI: 10.1016/j.pharma.2025.04.003
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-05086560. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.